FDA and MassBio Confirmed to Keynote at ACI's Life Sciences IP Due Diligence Conference

American Conference Institute (ACI) is pleased to announce that Julia Tierney, Chief of Staff of the U.S. Food and Drug Administration (FDA) and Kendalle Burlin O'Connell, President and COO of MassBio will be this year's keynote speakers.
 
 
ACI's Life Sciences IP Due Diligence Conference
ACI's Life Sciences IP Due Diligence Conference
BOSTON - Oct. 5, 2022 - PRLog -- American Conference Institute (ACI) is pleased to announce that Julia Tierney, Chief of Staff of the U.S. Food and Drug Administration (FDA) and Kendalle Burlin O'Connell, President and COO of MassBio will be this year's keynote speakers at ACI's 5th Annual Life Sciences IP Due Diligence Conference taking place at the The Westin Copley Place in Boston on November 15-16, 2022.

In addition to these esteemed keynote presenters, this year's faculty includes respected in-house counsel from Johnson & Johnson, Atalanta Therapeutics, Beam Therapeutics, and Biogen.

Kiera Mathey, 2022 Co-Chair and Associate Patent Counsel, IP Transactions at Johnson & Johnson, commented that, "Our speaker faculty will aim to provide you with best practices, tips and strategies on many different topics such as conducting Freedom to Operate, and analyzing issues like enforceability, ownership and inventorship for a spectrum of transactions. There's also a session on conducting due diligence with companies that are restructuring or insolvent and there will be a special three-part think tank on day two with the theme of bridging the gap between business and IP."

In response, Lisa J. Piccolo, Associate VP with ACI, noted, "we are honored to have Julia Tierney, Kendalle Burlin O'Connell, Kiera Mathey and Bart Newland (General Counsel at Atalanta Therapeutics), participate in this year's conference. Their presence at the event is testament to the "must-attend" status of this conference for all life sciences practitioners involved in the IP due diligence process."

Andrea Tredenick, Legal Analyst and Conference Producer at ACI, remarked, "We are proud to host the premier event for life sciences practitioners to gather and strategize the design and process for a successful and cost-effective IP due diligence analysis."  Tredenick added, "We look forward to bringing this year's event to Boston, the biopharma industry's new mecca, and are honored to work with this stellar group of life sciences professionals."

Full information on the forum can be found at https://bit.ly/3ChGh7k

# # #

A unique organization, American Conference Institute is devoted to providing the business intelligence that senior decision-makers need to respond to challenges both here in the US, and around the world.

Staffed by industry specialists, lawyers and other professionals, American Conference Institute operates as a think tank, monitoring trends and developments in all major industry sectors, the law, and public policy, with a view to providing information on the leading edge.

Contact
Shannon Kao
s.kao@americanconference.com
1-888-224-2480
End
Email:***@americanconference.com Email Verified
Tags:Life Sciences IP
Industry:Legal
Location:Boston - Massachusetts - United States
Subject:Events
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
American Conference Institute PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share